Hikma Pharmaceuticals Plc - Company Profile
Powered by
All the data and insights you need on Hikma Pharmaceuticals Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Hikma Pharmaceuticals Plc Strategy Report
- Understand Hikma Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Hikma Pharmaceuticals Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
25 Aug 2022 | Adalvo Enters into Licensing Agreement with Hikma Pharma | Licensing Agreement |
Adalvo
|
Hikma Pharmaceuticals Plc |
04 Apr 2022 | O7 Holding (O7 Therapy) Secures USD2.1 Million in Seed Funding | Venture Financing |
Lotus Ventures, Inc.
C-Ventures Primus
Hikma Ventures Ltd
|
O7 Therapy
|
30 Mar 2022 | Altoida Raises Additional USD14 Million in Series A Financing | Venture Financing |
Hikma Ventures Ltd
Fyrfly Venture Partners
btov Partners AG
HonorHealth
VI Partners AG
M Ventures
Alpana Ventures SA
Whitecap Venture Partners
|
Altoida Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer